A STUDY TO REVIEW THE APPROPRIATENESS OF DRUG DOSAGE IN RENALLY IMPAIRED PATIENT BY IDENTIFYING, ANALYSING AND ADJUSTING DOSAGES IN A TERTIARY CARE TEACHING HOSPITAL
ObjectivesÂ To identify and analyze drug dosing in renally impaired patient in a tertiary care teaching hospital and to categorize patients on the basis of gender, age, GFR (Glomerular Filtration Rate) and anemia.
MethodologyÂ A prospective interventional study was conducted on the drug dosage in renally impaired patient by identifying, analyzing, and adjusting. Ethical clearance was obtained from the IEC (Institutional Ethical Committee). The study was conducted on 103 patients with renal impairment for a period of six months. During ward rounds, cases were collected and collected data were assessed and analysed by using Micromedex, Lexicomp. For the possible interventions, the dosage errors were reported along with the evidence.
ResultsÂ Out of the 103 patients, 73 were males and 30 were females and majority of patients belonged to the age group between 41- 65 yrs. 56.31% and 43.69% of patients were in the category B and category C of GFR respectively. A total of 244 co-morbidities were present in 103 patients with HTN (Hypertension) and Type 2 DM (Diabetes Mellitus) the foremost. In total, 983 drugs were prescribed to the total patient with an average of 9.54 drugs per patient, 175 drugs required dosage adjustment.
ConclusionÂ The present study effectively reports all the interventions to the physicians along with the supporting data. Continuous medical education to the physicians together with pharmacists may reduce the chances of incongruity in drugs given to the renally impaired patients.
Key Words:Â Renal impairment, MDRD (Modification of Diet in Renal Disease), Creatinine Clearance, Dosage Adjustment
2. Sepideh E, Hamid RE, Farin RF, Fanak F. Assessment of drug dose adjustment in patients with kidney disease: opportunities for pharmacist involvement. Int J Pharm Pharm Sci. 2012;4(3):178-81.
3. Abdulrahman MA, Ahmed AE. Evalution of applying drug dose adjustment by physicians in patients with renal impairment. Saudi Pharmaceutical Journal. 2012;20:217-20.
4. Kidu G, Naod GS, Fantaahun M, Solomon A, Abrham W, Admassu A et. al. Drug dose adjustment practices in patients with renal impairment at ayder referral hospital, mekelle, northern ethiopia. Int. J. Pharm. Sci. Rev. Res. 2015;30(2):153-57.
5. Antje E, Martin B, Juliana JP, Kristina S, Thomas R, Justine R et.al. How to improve drug dosing for patients with renal impairment in primary care- a cluster-randomized controlled trial. BMC Family Practice. 2012;13(91):1-8.
6. Randall F, Lisa L. Prescribing in Renal Disease. Aust Prescr. 2007;30:17-20.
7. Modi CM, Modi FD, Mody SK, Patel HB. Pharmacokinetic of Renal Failure Therapy. IJPRBS. 2012;3:120-32.
8. Matthew PD, Thomas MP. Drug dosing in renal disease. Clin Biochem Rev. 2011;32(2):69â€“73.
9. Henok G, Yewondwossen T, Workineh S. Drug dosage adjustment in hospitalized patients with renal impairment at tikur anbessa specialized hospital, addis ababa, ethiopia. BMC Nephrology. 2015;16(158):1-9.
10. Sah SK, Wanakamanee U, Lerkiatbundit S, Regmi BM. Drug dosage adjustment of patients with impaired renal function at hospital discharge in a teaching hospital. J Nepal Health Res Counc. 2014;12(26):54-58.
11. Yahaya H, Rowaâ€™J AR, Noorizan AA, Rozina G. Drug use and dosing in chronic kidney disease. Annals Academy of Medicine. 2009;38(12):1095-03.
12. Nina PM, Ivica M, Monika T, Anka Z. Inappropriate drug dosage adjustments in patients with renal impairment. JNEPHROL. 2009;22:497-01.
13. Leon S, Susanna W, Andrew B. Applied biopharmaceutics & pharmacokinetics. 5th ed. USA: McGraw Hill Professional; 2004. Chapter 21, Dosage adjustment in renal and hepatic disease.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.